Clinical Blogs

myMatrixx has integrated e-prescribing and digital provider engagement technology into our workers’ compensation pharmacy program and it is an integral part of our online adjudication system.

As we continue to move into 2021, two of the biggest concerns in workers’ compensation pharmaceuticals remain the ongoing COVID-19 pandemic and the opioid misuse crisis.

On Wednesday April 14, myMatrixx Chief Clinical Officer, Phil Walls, was joined by Marcos Iglesias MD, Chief Medical Director of the Travelers and Constitution State Services to discuss the interaction between behavioral health and chronic pain management in workers’ compensation.

As the workers’ compensation industry moves into a new year, many of the major topics that will drive the field in 2021 are starting to come into focus.

In a new piece for Risk & Insurance, myMatrixx Chief Clinical Officer, Phil Walls, shares four major reasons why people in workers’ comp, and the larger health care industries, need to stay focused on opioid misuse.

As the workers’ comp and pharmaceuticals industries continue to make progress in the fight against opioid misuse, it’s important to remain vigilant around new pain treatments that are filling this vacuum.

On Wednesday, January 27th, myMatrixx Chief Clinical Officer, Phil Walls, will join the Hartford’s Chief Medical Officer, Adam L. Seidner, in a virtual session for the National Workers’ Compensation and Disability Conference (NWCDC).

A Message from myMatrixx President, Mike Cirillo. myMatrixx works hard, every day, to be your trusted partner for better workers’ compensation PBM support. That means bringing innovative solutions to your problems, identifying opportunities to improve the health and well-being of your injured...

myMatrixx Clinical Account Executive Shanea McKinney is a regular speaker for RIMS, the risk management society, and their Professional Exchange of Risk Knowledge, or PERK, program.

Featured in the NWCDC CompTalk series, Phil’s newest presentation is “Risky Business: the Journey of Fentanyl from Licit to Illicit Drug,” offering a wide-ranging history of both the pharmacology of the drug and its path to becoming one of the world’s most dangerous illegal substances